EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models

Gyeong-Seo Park iD, Somin Lee, Min A Jeong, So Young Lee, Dong-Geun Cho, WonIl Cho, Seung-Chai Kim iD, Hwan-Ju Kim, Taek Geun Lee, Chang-Gi Jeong, Won-Il Kim iD, Yeonsu Oh iD und 3 weitere

Pathogens · 2024

DOI: 10.3390/pathogens13090729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Gyeong-Seo Park und 14 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine Lab, WOOGENE B&G Co., Ltd., Seoul 07299, Republic of Korea. Hauptthemen laut MEDLINE: Corynebacterium pseudotuberculosis, Goats, Vaccines, Inactivated, Lymphadenitis. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups (MSS, Republic of Korea), Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Caseous lymphadenitis (CLA) is a chronic and subclinical bacterial disease of ruminants caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis) infection. Until 2014, there were no reports of CLA outbreaks in South Korea; however, the prevalence of CLA cases has steadily increased. In this study, we used recently obtained field isolates to develop the first inactivated CLA vaccine in South Korea and evaluated it in various animal models. The inactivated vaccine was evaluated for virulence and effectiveness. Mice were tested for virulence and immunization challenges, and guinea pigs and Korean Native Black Goats (KNBGs) evaluated various vaccine concentrations to determine the optimal dose and effectiveness. In the case of KNBGs, clinical symptoms were not observed after vaccination. In addition, CLA-specific IgG was detected at a significantly (p < 0.05) high level and was maintained. In histopathological evaluations, inflammation was predominantly observed in the prefemoral lymph nodes in the non-vaccinated+CHAL group. The genetic diversity of C. pseudotuberculosis, which has become widespread in South Korea, is less than 0.5% our vaccine is expected to prevent infection by a wide range of strains effectively. In summary, our CLA vaccine can potentially prevent CLA and foster the growth of South Korea’s domestic KNBG industry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Corynebacterium pseudotuberculosisGoatsVaccines, InactivatedLymphadenitisDisease Models, AnimalCorynebacterium InfectionsBacterial VaccinesAnimalsRepublic of KoreaGuinea PigsMiceFemaleAntibodies, Bacterial

Stichwörter der Autor:innen

Caseous Lymphadenitis (CLA)Corynebacterium pseudotuberculosisKorean Native Black Goats (KNBGs)animal trialsinactivated vaccine

Substanzen

Vaccines, InactivatedBacterial VaccinesAntibodies, Bacterial

Autor:innen und Institutionen

  • Vaccine Lab, WOOGENE B&G Co., Ltd., Seoul 07299, Republic of Korea.
  • Osan Black Goat Farm, Gokseong 57518, Republic of Korea.
  • College of Veterinary Medicine, Bio-Safety Research Institute, Jeonbuk National University, Iksan 54596, Republic of Korea.
  • College of Veterinary Medicine and Institute of Veterinary Science, Kwangwon National University, Chuncheon 24341, Republic of Korea.

ORCID-Profile: Gyeong-Seo Park, Seung-Chai Kim, Won-Il Kim, Yeonsu Oh, Ho-Seong Cho, Chonghan Kim

Förderung

  • Ministry of SMEs and Startups (MSS, Republic of Korea)
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry

Zitieren

APA

Park, G. S., Lee, S., Jeong, M. A., Lee, S. Y., Cho, D. G., Cho, W., Kim, S. C., Kim, H. J., Lee, T. G., Jeong, C. G., Kim, W. I., Oh, Y., Cho, H. S., Seo, B. J., & Kim, C. (2024). First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models. Pathogens. https://doi.org/10.3390/pathogens13090729

Vancouver

Park GS, Lee S, Jeong MA, Lee SY, Cho DG, Cho W, et al. First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models. Pathogens. 2024. doi:10.3390/pathogens13090729

BibTeX
@article{Park2024,
  author = {Park, Gyeong-Seo and Lee, Somin and Jeong, Min A and Lee, So Young and Cho, Dong-Geun and Cho, WonIl and Kim, Seung-Chai and Kim, Hwan-Ju and Lee, Taek Geun and Jeong, Chang-Gi and Kim, Won-Il and Oh, Yeonsu and Cho, Ho-Seong and Seo, Byoung-Joo and Kim, Chonghan},
  title = {First Trial of a Novel Caseous Lymphadenitis Inactivated Vaccine in South Korea: Experimental Evaluation across Various Animal Models},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13090729}
}
Kostenlos starten →